Literature DB >> 1691018

Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2.

G Karlsson1, J E Månsson, C Wikstrand, D Bigner, L Svennerholm.   

Abstract

Several derivatives of ganglioside GM2 were synthesized for mapping of the binding epitope of a monoclonal antibody raised against this ganglioside. The GM2 ganglioside was modified in both the hydrophobic and the hydrophobilic part of the molecule. The synthesized derivatives were characterized with fast atom bombardment mass spectrometry (FAB-MS). Affinity of the monoclonal antibody for the GM2 derivatives was determined by enzyme-linked immunosorbent assay (ELISA) on microtitre plates or by TLC immunostaining. Modifying the GM2 sialic acid by deacetylation or blocking of the carboxyl moiety abolished the binding to the monoclonal antibody while the cleaving of the glycol group on the sialic acid tail led to a 70% reduced binding affinity. Removal of the fatty acid (lyso-GM2) eliminated the binding to the antibody. GM2 derivatives with fatty acid moieties of 8 carbon atoms or less showed almost no reactivity. GM2 with saturated fatty acids 16:0, 18:0 and 20:0 had binding affinity similar to natural GM2, while the 24:0 fatty acid had only half the binding affinity. The results demonstrate the importance of ganglioside fatty acid composition with regard to ligand binding between the monoclonal antibody and its specific ganglioside antigen. Thus, caution must be shown in the application of immunaffinity methods with monoclonal antibodies for the quantitative determination of glycosphingolipids from different tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691018     DOI: 10.1016/0005-2760(90)90026-t

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae.

Authors:  Saara Vainio; Sanna Heino; Jan-Eric Mansson; Pam Fredman; Esa Kuismanen; Outi Vaarala; Elina Ikonen
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

2.  Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids.

Authors:  Yumi Tagawa; Wouter Laroy; Leonardo Nimrichter; Susan E Fromholt; Ann B Moser; Hugo W Moser; Ronald L Schnaar
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

3.  Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.

Authors:  K M Hedberg; B Dellheden; C J Wikstrand; P Fredman
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

4.  Ceramide structure predicts tumor ganglioside immunosuppressive activity.

Authors:  S Ladisch; R Li; E Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

5.  Sulfatide is associated with insulin granules and located to microdomains of a cultured beta cell line.

Authors:  Maria Blomqvist; Thomas Osterbye; Jan-Eric Månsson; Thomas Horn; Karsten Buschard; Pam Fredman
Journal:  Glycoconj J       Date:  2002-07       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.